1.
Longo R, Thiebaut V, Legros P-O, Campitiello M, Plastino F, Goetz C, et al. Is the TCH-P regimen active in early or locally advanced HER2-positive breast cancer? Results of a retrospective study. AO [Internet]. 2022 Nov. 2 [cited 2024 Nov. 24];61(11):1394-9. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/23848